"Overall survival (OS) will be the primary endpoint with secondary endpoints including progression-free survival (PFS), adverse events, and immune monitoring."
That's what I like to see - now we are on the right path.
announcement out, page-5
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
0.010(2.94%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 36.0¢ | 33.5¢ | $1.461M | 4.176M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 808550 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 228572 | 55 |
View Market Depth
| Last trade - 14.37pm 18/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |